Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain

Phase 1 Study of Low Level Laser Therapy Versus Naproxen

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01659372

Enrollment

Registered

2012-08-07

Start date

2012-06-30

Completion date

2013-03-31

Last updated

2012-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

TMD

Keywords

temporomandibular disorder, myofascial pain syndrome

Brief summary

tempromandibuar disorders are a group of heterogenous pathologies affecting temporomandibular joint,muscles or both.in more than 90%of cases muscles are the origin of pain.TMDs cause pain,movement disability and deficit in quality of life.in more than 90%of cases pain is the major complaint.we run this investigation to find the analgesic effct of low level laser therapy versus pharmacotherapy with naproxen in improving pain.

Interventions

RADIATIONlow level laser therapy

DRUGNaproxen

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

15 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* patients with TMD affecting masticatory muscles

Exclusion criteria

* systemic disease * GI problem * pregnancy * epidermal cancer

Design outcomes

Primary

Measure	Time frame	Description
reduction of paim measured by VAS	1 month	VAS is visual analogue scale

Countries

Iran

Contacts

Primary Contactsaranaz azari marhabi, post graduate student

saranazazari@yahoo.com00989190129151

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026